| Net income | |
| Income from discontinued operations, net of a tax | |
| Depreciation and amortization | 23.07M |
| Non-cash interest, net | |
| Non-cash stock-based compensation | 21.04M |
| Deferred income taxes | 6.63M |
| Loss on convertible notes | 0 |
| (Gain) loss on investments | 0 |
| Accounts receivable | 21.06M |
| Prepaid expenses and other, net | 2.75M |
| Accrued expenses and other long-term liabilities | -9.75M |
| Deferred revenue | -464K |
| Net cash provided by continuing operations | |
| Net cash used in discontinued operations | |
| Net cash provided by operating activities | 122.28M |
| Proceeds from sales of available-for-sale securities | |
| Proceeds received from ARS option | |
| Purchases of property and equipment | -24.45M |
| Finalization of sale price of discontinued operations | |
| Net cash provided by investing activities | |
| Proceeds from exercise of stock options | 52.7M |
| Cash used for withholding taxes due on stock-based awards | |
| Net proceeds from issuance of 2.50% Notes and 2.25% Notes | 350.39M |
| Repurchases of 1.75% Notes and 3 1/8% Notes | |
| Purchases of treasury stock | -22.45M |
| Excess tax benefit on stock-based awards | 26.23M |
| Net cash provided by (used in) financing activities | |
| Net increase in cash and cash equivalents | -552.57M |
| Cash and cash equivalents at beginning of period | 641.17M |
| Cash and cash equivalents at end of period | 88.6M |